VistaGen Therapeutics Inc (VTGN) - Medical Equipment - Deals and Alliances Profile

VistaGen Therapeutics Inc (VTGN) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME123122D
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company's pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate receptor glycine B intended to treat major depressive disorder. It conducts research on their human pluripotent stem cell platform to predict toxic chemicals in heart. The company conducts clinical trials of its product in treatment of chronic neuropathic pain, epilepsy, huntington's disease and parkinson's disease. It partners with other healthcare industries for researching and assessing the drug effects on cardiac risk. VistaGen is headquartered in South San Francisco, California, the US.

VistaGen Therapeutics Inc (VTGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

VistaGen Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

VistaGen Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

VistaGen Therapeutics Inc, Medical Equipment, Deal Details 10

Partnerships 10

VistaGen Therapeutics Enters Into Agreement With Celsis In Vitro Technologies 10

Equity Offering 11

VistaGen Therapeutics Raises USD4.8 Million in Private Placement of Shares 11

VistaGen Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 12

Vistagen Therapeutics Raises USD2.4 Million in Public Offering of Shares and Warrants 13

VistaGen Therapeutics Raises USD10 Million in Public Offering of Shares and Warrants 15

VistaGen Therapeutics Completes First Tranche Of Private Placement Of Shares For USD 0.025 Million 17

VistaGen Therapeutics Inc-Key Competitors 18

VistaGen Therapeutics Inc-Key Employees 19

VistaGen Therapeutics Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

Aug 14, 2018: VistaGen Therapeutics announces fiscal 2019 first quarter financial results 21

Jun 26, 2018: VistaGen Therapeutics Announces Fiscal Year 2018 Financial Results 23

Feb 12, 2018: VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial Results 25

Nov 09, 2017: VistaGen Therapeutics Reports Second Fiscal Quarter 2018 Financial Results and Provides Business Update 26

Aug 14, 2017: VistaGen Therapeutics Reports First Fiscal Quarter 2018 Financial Results and Provides Business Update 27

Jun 29, 2017: VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update 29

Feb 13, 2017: VistaGen Therapeutics Reports Fiscal Third Quarter 2017 Financial Results and Provides Corporate Update 31

Corporate Communications 33

Aug 21, 2017: VistaGen Therapeutics Expands VistaStem's Scientific Advisory Board with Appointment of Medicinal Chemistry Expert, David Rotella, PhD 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

VistaGen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

VistaGen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

VistaGen Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

VistaGen Therapeutics Inc, Medical Equipment, Key Facts, 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

VistaGen Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

VistaGen Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8

VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

VistaGen Therapeutics Enters Into Agreement With Celsis In Vitro Technologies 10

VistaGen Therapeutics Raises USD4.8 Million in Private Placement of Shares 11

VistaGen Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 12

Vistagen Therapeutics Raises USD2.4 Million in Public Offering of Shares and Warrants 13

VistaGen Therapeutics Raises USD10 Million in Public Offering of Shares and Warrants 15

VistaGen Therapeutics Completes First Tranche Of Private Placement Of Shares For USD 0.025 Million 17

VistaGen Therapeutics Inc, Key Competitors 18

VistaGen Therapeutics Inc, Key Employees 19

VistaGen Therapeutics Inc, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

VistaGen Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17980
Site License
USD 500 INR 35960
Corporate User License
USD 750 INR 53940

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com